Public filings / DYN on Yahoo Finance (opens in a new tab)
DYN: insider buying, 13F holders, analyst moves
Dyne Therapeutics Inc - US
A summary of public filings about Dyne Therapeutics Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
4 of our 100 managers hold DYN
Combined reported value $150.1M; 2 sold out since Q1 2026.
Holders among our 100 managers: 1 in Q3 2023, 4 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Perceptive Advisors | $59.7M | 0.93% | Trimmed |
| Samlyn Capital | $39.0M | 0.65% | Trimmed |
| Deep Track Capital | $33.3M | 0.49% | Trimmed |
| Baker Bros. Advisors | $18.1M | 0.09% | Unchanged |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.